Skip to search formSkip to main contentSkip to account menu

Exviera

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Viekirax ® / Exviera ® Wirksamkeit im klinischen Alltag bestätigt
2016
2016
Direct‐acting antiviral drugs for the treatment of hepatitis C
New direct‐acting antiviral drug treatments for hepatitis C are more effective, easier to take and have fewer side‐effects than… 
2016
2016
Dasabuvir (Exviera). Only assessed as part of a difficult-to-manage combination in hepatitis C.
  • Prescrire international
  • 2016
  • Corpus ID: 12564856
In late 2015, the first-choice treatment for patients with chronic hepatitis C due to a genotype 1 virus (HCV-1) was the… 
2016
2016
Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In Greece
2016
2016
HEP-09 - Description de la population incluse dans l’autorisation temporaire d’utilisation (ATU) de cohorte obtenue pour Viekirax et Exviera en France
2015
2015
Industry chases pan-genotypic and shorter HCV treatments
575 replication to cure infection [using] all-oral drug [combinations] without interferon,” says Jean-Michel Pawlotsky, of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)